Literature DB >> 15896713

Epigenetic regulation of the dendritic cell-marker gene ADAM19.

Achim Ehrnsperger1, Michael Rehli, Pham Thu-Hang, Marina Kreutz.   

Abstract

Human ADAM19 (MADDAM) is a molecular marker for human dendritic cells and not expressed in macrophages. To investigate its cell-type-specific expression, we defined the transcriptional start site and the proximal promoter. Sequence analysis of the promoter revealed putative binding sites for several transcription factors including Sp1, Sp3, NF-kappaB, and VDR. A minimal promoter construct of 150 bp showed little difference in reporter activity between macrophages and dendritic cells. Transfection of monocytic THP-1 with the 150-bp fragment also resulted in significant reporter activity, despite the lack of endogenous MADDAM expression. TSA, a known inhibitor of histone deacetylation, led to a dose-dependent induction of MADDAM mRNA in THP-1. ChIP assays demonstrated high levels of acetylated histone H3 in the proximal promoter region of the MADDAM gene in TSA-treated THP-1 cells and dendritic cells as compared to macrophages, indicating an important role of histone acetylation in the regulation of the MADDAM gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896713     DOI: 10.1016/j.bbrc.2005.04.149

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Cardiac outflow tract development relies on the complex function of Sox4 and Sox11 in multiple cell types.

Authors:  Mandy H Paul; Richard P Harvey; Michael Wegner; Elisabeth Sock
Journal:  Cell Mol Life Sci       Date:  2013-12-06       Impact factor: 9.261

2.  Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer.

Authors:  Michael Wy Chan; Yi-Wen Huang; Corinna Hartman-Frey; Chieh-Ti Kuo; Daniel Deatherage; Huaxia Qin; Alfred Sl Cheng; Pearlly S Yan; Ramana V Davuluri; Tim H-M Huang; Kenneth P Nephew; Huey-Jen L Lin
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

3.  ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice.

Authors:  Lakshini Weerasekera; Caroline Rudnicka; Qing-Xiang Sang; Joanne E Curran; Matthew P Johnson; Eric K Moses; Harald H H Göring; John Blangero; Jana Hricova; Markus Schlaich; Vance B Matthews
Journal:  Mediators Inflamm       Date:  2017-02-07       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.